Scott I. Simon, Ph.D.

AIMBE College of Fellows Class of 2006
For contributions to cell mechanics, membrane adhesion, and methods to study membrane adhesion under the influence of fluid shear stress.

UC Davis BME Professor Elected to FASEB Leadership Role

Via UC Davis | July 23, 2015

Scott I. Simon, Professors in the UC Davis Department of Biomedical Engineering, has been elected to a leadership position by the Federation of American Societies for Experimental Biology (FASEB).

Simon has been named Vice President-Elect for Science Policy. His appointment is effective as of July 1.

Simon completed both his master’s degree (1984) and doctorate (’88) in biomedical engineering at UC San Diego. After postdoctoral work at California’s Scripps Research Institute and New Mexico’s Los Alamos National Laboratory, he joined the faculty at Rice University. He next spent seven years at the Baylor College of Medicine’s Department of Pediatrics, in Houston, Texas.

Professor Scott Simon of the UC Davis Department of Biomedical Engineering.
He was recruited by UC Davis in 1999, as one of the founding members of the new Department of Biomedical Engineering, where he became a full professor in 2002. He currently serves as department vice chair, and deputy editor of the journal Annals of Biomedical Engineering. Simon recently completed a term on the National Institutes of Health (NIH) Bioengineering Technology and Surgical Sciences study section, and now serves on the NIH College of CSR Reviewers.

He has a longstanding interest in the mechanisms that govern leukocyte adhesion and signaling during inflammatory disease, and his research focuses on white blood cell recruitment in cardiovascular and infectious diseases. His group has investigated how selectins, integrins and ICAM (Intercellular Adhesion Molecule) receptors mediate leukocyte capture in fluid shear, and developed novel microfluidic vascular mimetic lab-on-a-chip diagnostics for assessing biomarkers that predict the onset of inflammatory disease. The goal is to provide low-cost, real-time, point-of-care tools to study tissue-level consequences and biomarkers, in order to assess disease progression.

He was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) in 2005, and a Fellow of the Biomedical Engineering Society (BMES) in 2010.